← Back to search

ADAPTIVE BIOTECHNOLOGIES CORPORATION

SEATTLE, WA, 98109

UnclaimedClaim this profile (free)
Other Than Small Business

Prime contracting experience

2 records from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Prime
Department of Defense
Defense Health Agency
CLONOSEQ MINIMAL RESIDUAL DISEASE IN-VITRO DIAGNOSTIC ARRAY FOR THE DEPARTMENT OF PATHOLOGY AT WALTER REED NATIONAL MILITARY MEDICAL CENTER—$385,920Aug 29, 2024Aug 29, 2019 – Feb 28, 2025
Prime
Department of Health and Human Services
National Institutes of Health
COVID 19 FUNDED IMMUNOSEQ SEQUENCING SERVICES FOR COVID-19 RESEARCH PROJECT—$308,400Nov 10, 2022Nov 10, 2022 – May 9, 2023

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

  • Department of DefenseGov-sourced
  • Department of Health and Human ServicesGov-sourced

Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.

ADAPTIVE BIOTECHNOLOGIES CORPORATION – Seattle, WA | UEI DMW5BNQ331K9 | FedSub